MetaCap

Design Therapeutics Statistics

NASDAQ: DSGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.02-0.30 (-3.22%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Design Therapeutics by the numbers

Design Therapeutics has a market capitalization of $577.6 million based on 64.04M shares outstanding. With trailing EPS of $-1.20, Design Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.0% below its 50-day average and 25.9% below its 200-day average.

Average daily trading volume is 554.69K shares, or about $5.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DSGN valuation vs. peer median

DSGN compared with the median of 8 peer companies
MetricDSGNPeer medianDifference
Market cap$577.61M$555.46M+4%
Avg. volume554.69K1.41M-61%

Peer median across 8 companies: IMMX, ANNX, GERN, BCAX, ANL, ACRS, AVBP, CBIO.

Valuation

Price and trading

Previous close
9.32
Open
9.18
Day range
8.97 – 9.57
52-week range
8.21 – 17.25
52-week change
+8.02%
Beta
—
Volume
281.93K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
577.61M
Forward Pe
-5.81
Eps
-1.20
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.25
Week52 Low
8.21
Avg Volume
554.69K
Shares Outstanding
64.04M
Ma50
11.14
Ma200
12.17
Earnings Date
Nov 4, 2026
Pct From52w High
-47.71%
Pct From52w Low
9.87%

Related